Published: Vol 8, Iss 13, Jul 5, 2018 DOI: 10.21769/BioProtoc.2908 Views: 8514
Reviewed by: Yannick DebingVasudevan AchuthanAnonymous reviewer(s)
Protocol Collections
Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics
Related protocols
In vitro Drug Susceptibility Assay for HBV Using Southern Blotting
Sung Hyun Ahn [...] Kyun-Hwan Kim
Apr 20, 2015 10734 Views
Isolation of Exosomes from Semen for in vitro Uptake and HIV-1 Infection Assays
Marisa N. Madison [...] Chioma M. Okeoma
Apr 5, 2017 11742 Views
Abstract
The stable HBV-transfected cell lines, which based on stable integration of replication-competent HBV genome into hepatic cells, are widely used in basic research and antiviral drug evaluation against HBV. However, previous reported strategies to generate HBV-replicating cell lines, which primarily rely on random integration of exogenous DNA by plasmid transfection, are inefficient and time-consuming. We newly developed an all-in-one Sleeping Beauty transposon system (denoted pTSMP-HBV vector) for robust generation of stable HBV-replicating cell lines of different genotype. The pTSMP-HBV vector contains HBV 1.3-copy genome and dual selection markers (mCherry and puromycin resistance gene), allowing rapid enrichment of stably-transfected cells via red fluorescence-activated cell sorting and puromycin antibiotic selection. In this protocol, we described the detailed procedure for constructing the HBV-replicating stable cells and systematically evaluating HBV replication and viral protein expression profiles of these cells.
Keywords: HBVBackground
Chronic hepatitis B virus (HBV) infection is currently a major public health burden, affecting over 240 million individuals globally (Witt-Kehati et al., 2016). Patients with chronic HBV have an elevated risk of chronic active hepatitis, cirrhosis, or primary hepatocellular carcinoma (HCC) (Schweitzer et al., 2015). Current treatments with interferon-α or nucleoside analogs do not eradicate the virus, and their effects on clearing hepatitis B surface antigen (HBsAg) are limited (Lucifora and Protzer, 2016; Soriano et al., 2017). Therefore, there is an urgent need for the development of novel antiviral inhibitors (Nassal, 2015).
A cell culture model for evaluating the activity of new agents against HBV is an important tool for new drug development. The stable HBV-replicating cell lines, which carry replication-competent HBV genome stably integrated into the genome of human hepatoma cell lines (Huh7 and/or HepG2), are widely used to evaluate the effects of antiviral agents (Witt-Kehati et al., 2016). The stable HBV-producing human hepatoma cell lines (HepG2.2.15 and HepaAD38) integrated the D-genotype HBV genome, which are widely used in antiviral research (Chang et al., 1987; Ladner et al., 1997). However, stable HBV-producing cell lines of genotypes A, B, and C are not commonly used in the research field. Therefore, there is a need to develop cell lines of HBV genotypes A-C for drug development.
The Sleeping Beauty (SB) transposon system, derived from teleost fish sequences, is extremely effective at delivering DNA to vertebrate genomes, including those of humans (Structure of SB can be seen in Figure 1A). Sleeping Beauty transposition is a cut-and-paste process, during which the element ‘jumps’ from one DNA molecule to another (Figure 1B) (Ivics and Izsvak, 2011). Since its reconstruction in 1997 from the salmonid fish genome (Ivics et al., 1997), the SB system has been undergoing several modifications to improve its efficacy (Geurts et al., 2003; Baus et al., 2005; Score et al., 2006). The development of the hyperactive transposase SB100X has increased approximately 100-fold of efficiency compared with the first-generation transposase (Mátés et al., 2009), which is expected to facilitate widespread applications in functional genomics and gene therapy (Izsvak and Ivics, 2004).
Figure 1. The Sleeping Beauty transposable element and its transposition. A. The Sleeping Beauty (SB) system. The transposase gene (yellow rectangle) is flanked by terminal inverted repeats (IR/DRs, blue arrows), each containing two binding sites for the transposase (small green arrows). The transposase consists of an N-terminal, DNA-binding domain (PAI and RED), a nuclear localization signal (NLS), a C-terminal and catalytic domain (DDE). B. Transposition. The transposase gene within the element can be replaced by a therapeutic gene, and the resultant transposon can be maintained in a simple plasmid vector. The transposase is supplied in trans. The transposase binds to its binding sites within the IR/DR repeats and, together with host factors such as HMGB1, forms a synaptic complex, in which the ends of the transposon are paired. The transposon is excised from the donor molecule and integrates into a new location.
Materials and Reagents
Equipment
Procedure
5x PrimeSTAR GXL buffer | 5 μl |
HBx-probe-F (10 μM) | 1 μl |
HBx-probe-R (10 μM) | 1 μl |
dNTP Mix (2.5 μM) | 2 μl |
DIG-dUTP | 2 μl |
pGEM-1.3 HBV | 1 μl |
PrimeSTAR GXL DNA polymerase | 1 μl |
ddH2O | 37 μl |
2x Premix Ex Taq (Probe qPCR) | 10 μl |
KHF2 (100 μM) | 0.1 μl |
KHR1 (100 μM) | 0.1 μl |
KHP4 (100 μM) | 0.05 μl |
DEPC water | 4.75 μl |
Template | 5 μl |
Notes
Recipes
Acknowledgments
We would like to acknowledge the following publication on which this protocol is based: Wu et al. (2016). The authors declare no competing financial interests.
References
Article Information
Copyright
© 2018 The Authors; exclusive licensee Bio-protocol LLC.
How to cite
Zheng, J., Cao, J. and Yuan, Q. (2018). Sleeping Beauty Transposon-based System for Rapid Generation of HBV-replicating Stable Cell Lines. Bio-protocol 8(13): e2908. DOI: 10.21769/BioProtoc.2908.
Category
Microbiology > Microbe-host interactions > In vitro model
Microbiology > Microbe-host interactions > Virus
Cell Biology > Cell structure > Chromosome
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link